CORDIS


Also found in: Medical, Wikipedia.
AcronymDefinition
CORDISCommunity Research and Development Information Service (Europe)
CORDISCommunity R&D Information Service
CORDISCardiovascular Occupational Risk Factors Determination in Israel (American Journal of Epidemiology)
References in periodicals archive ?
Cardinal Health and Medinol entered into a long-term distribution agreement that gives Cordis, Cardinal Healths interventional vascular business, the rights to sell Medinols coronary stent portfolio, which now includes the EluNIR DES and NIRxcell, a cobalt-chromium bare metal stent (BMS), in the U.
The term ectopia cordis is derived from Latin where the word ectopic means "outside or out of place" and cordis means "heart," according to the (https://www.
Under a long-term distribution agreement, Cordis, Cardinal Health's interventional vascular business, has been granted the rights to sell Medinol's coronary stent portfolio, which now includes the EluNIR DES and NIRxcell, a cobalt-chromium bare metal stent (BMS), in the US.
There was also the fragrance, a refreshing blend of citrus and mint formulated especially for Cordis by master perfumer Christophe Laudemiel.
Cordis will offer an expanded portfolio of products to further support the treatment of patients undergoing percutaneous coronary intervention (PCI), from access to intervention and closure.
Ca,L] prior to chest wall impact should reduce the incidence of VF in commotio cordis.
The Cordis business is engaged in the development and manufacture of interventional vascular technology and generated net revenues of approximately USD 780m in 2014.
The launch of Cordis, Hong Kong is a significant milestone in our long-term growth plan to introduce Cordis hotels and resorts across the region," said Robert Warman, chief executive officer of Langham Hospitality Group.
Keywords: Pentalogy of Cantrell, Ectopia cordis, midline developmental anomalies
Cordis had annual sales in 2014 of about $780 million, split almost evenly between cardiology and endovascular products.
Cardinal Health (NYSE: CAH) said it has plans to acquire Johnson & Johnson's Cordis business for USD1.
Developed to complement the CORDIS PTA portfolio as a next- generation, high-performance workhorse .